Evidence map›Paper›PMID 30308068›Full record

ArticlePLoS pathogens2018

CD8+ lymphocyte control of SIV infection during antiretroviral therapy.

Youfang Cao, Emily K Cartwright, Guido Silvestri, Alan S Perelson

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Modelling HIV-1 control and remission.NPJ systems biology and applications · 2024
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. CD8Nature communications · 2023
    Article
  10. Evolution during primary HIV infection does not require adaptive immune selection.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  11. Immune-viral dynamics modeling for SARS-CoV-2 drug development.Clinical and translational science · 2021
    Article
  12. Article
  13. The CD8Microbiology and molecular biology reviews : MMBR · 2021
    Review
  14. Article
  15. Role of NKG2a/ciScience · 2021
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Towards multiscale modeling of the CD8Wiley interdisciplinary reviews. Systems biology and medicine · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Youfang CaoTheoretical Biology and Biophysics (T-6), Los Alamos National Laboratory, Los Alamos, NM, United States of America.ORCID 0000-0002-5880-0006
Emily K CartwrightEmory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, GA, United States of America.
Guido SilvestriEmory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, GA, United States of America.
Alan S PerelsonTheoretical Biology and Biophysics (T-6), Los Alamos National Laboratory, Los Alamos, NM, United States of America.ORCID 0000-0002-2455-0002
Emory University · USLos Alamos National Laboratory · US

Funding

Yerkes National Primate Research Center Role of type-I IFN in regulating COVID-19 induced inflammation and pathogenesisP51OD011132 · OD · EMORY UNIVERSITY · PI Joon Sup Lee · 2012 to 2026
$167.0M
Viral Testing Core-Maintenance of the SPF Breeding Colonies at Yerkes National Primate Research CenterU42OD011023 · OD · EMORY UNIVERSITY · PI Joyce Kimberly Cohen · 2018 to 2026
$17.5M
Antiviral role of CD8+ T cells in ART-treated SIV-infected macaquesR01AI125064 · NIAID · EMORY UNIVERSITY · PI SILVESTRI, GUIDO · 2016 to 2025
$8.7M
Viral dynamics of rebound and control following early treatment of HIV/SIVP01AI131365 · NIAID · BOSTON COLLEGE · PI WHITNEY, JAMES BURTON · 2017 to 2021
$7.5M
Modeling Viral and T Lymphocyte DynamicsR01OD011095 · OD · TRIAD NATIONAL SECURITY, LLC · PI PERELSON, ALAN S · 2012 to 2024
$5.0M
Immune System Modeling/HIVR01AI028433 · NIAID · UNIVERSITY OF CALIF-LOS ALAMOS NAT LAB · PI PERELSON, ALAN S · 1990 to 2021
$3.7M
NIAID NIH HHS P01 AI131365NIAID NIH HHS R01 AI028433NIAID NIH HHS R01 AI125064NIH HHS P51 OD011132NIH HHS R01 OD011095NIH HHS U42 OD011023
6 · The paper itself

Abstract

CD8+ lymphocytes play an important role in suppressing in vivo viral replication in HIV infection. However, both the extent to which and the mechanisms by which CD8+ lymphocytes contribute to viral control are not completely understood. A recent experiment depleted CD8+ lymphocytes in simian immunodeficiency virus (SIV)-infected rhesus macaques (RMs) on antiretroviral treatment (ART) to study the role of CD8+ lymphocytes. CD8+ lymphocytes depletion resulted in temporary plasma viremia in all studied RMs. Viral control was restored when CD8+ lymphocytes repopulated. We developed a viral dynamic model to fit the viral load (VL) data from the CD8 depletion experiment. We explicitly modeled the dynamics of the latent reservoir and the SIV-specific effector cell population including their exhaustion and their potential cytolytic and noncytolytic functions. We found that the latent reservoir significantly contributes to the size of the peak VL after CD8 depletion, while drug efficacy plays a lesser role. Our model suggests that the overall CD8+ lymphocyte cytolytic killing rate is dynamically changing depending on the levels of antigen-induced effector cell activation and exhaustion. Based on estimated parameters, our model suggests that before ART or without ART the overall CD8 cytolytic killing rate is small due to exhaustion. However, after the start of ART, the overall CD8 cytolytic killing rate increases due to an expansion of SIV-specific CD8 effector cells. Further, we estimate that the cytolytic killing rate can be significantly larger than the cytopathic death rate in some animals during the second phase of ART-induced viral decay. Lastly, our model provides a new explanation for the puzzling findings by Klatt et al. and Wong et al. that CD8 depletion done immediately before ART has no noticeable effect on the first phase viral decay slope seen after ART initiation Overall, by incorporating effector cells and their exhaustion, our model can explain the effects of CD8 depletion on VL during ART, reveals a detailed dynamic role of CD8+ lymphocytes in controlling viral infection, and provides a unified explanation for CD8 depletion experimental data.

Indexed as

Virus ReplicationAnimalsAnti-Retroviral AgentsCD8-Positive T-LymphocytesLymphocyte DepletionMacaca mulattaSimian Acquired Immunodeficiency SyndromeSimian Immunodeficiency VirusViral LoadViremiaAnti-Retroviral Agents

Identifiers

PMID30308068
PMCPMC6199003
OpenAlexW2897165284

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.